成都先导股价跌5.19%，万家基金旗下1只基金重仓，持有3.02万股浮亏损失5.86万元

Group 1 - Chengdu Xian Dao Pharmaceutical Development Co., Ltd. experienced a decline of 5.19% in stock price, reaching 35.46 CNY per share, with a trading volume of 607 million CNY and a turnover rate of 4.17%, resulting in a total market capitalization of 14.208 billion CNY [1] - The company, established on February 22, 2012, and listed on April 16, 2020, specializes in early-stage drug discovery services using its core DEL technology, with 99.97% of its revenue coming from new drug research services [1] - The revenue breakdown includes customized services at 59.92%, full-time equivalent services at 27.20%, and other services at 12.84%, with a negligible 0.03% from supplementary sources [1] Group 2 - According to data from the top ten holdings of funds, Wan Jia Fund has one fund heavily invested in Chengdu Xian Dao, specifically the Wan Jia Quantitative Tongshun A (005650), which held 30,200 shares, accounting for 1.91% of the fund's net value, ranking as the tenth largest holding [2] - The estimated floating loss for the fund today is approximately 58,600 CNY [2] - Wan Jia Quantitative Tongshun A was established on May 4, 2018, with a latest scale of 29.9221 million CNY, achieving a year-to-date return of 7.53% and a one-year return of 37.32% [2]